XIAP and cancer: These findings indicate that the inhibition of δ-opioid receptors induces cancer cell apoptosis via XIAP regulation and provide a rationale for further developing the use of TRAIL to inhibit δ-opioid receptors and overcome apoptosis resistance in various human cancer cells.